ZIOPHARM Oncology to Present at the 4th Annual JMP Healthcare Focus – MSN MoneyTo access the live audio webcast, please visit the Investor Relations section at www.ziopharm.com . The webcast will be archived for ninety days. About ZIOPHARM Oncology, Inc.: ZIOPHARM Oncology is a biopharmaceutical company engaged in the
Location may affect [...]
Archive for September, 2009
ZIOPHARM Oncology to Present at the 4th Annual JMP Healthcare Focus – MSN Money
Wednesday, September 30th, 2009Posted in Uncategorized | No Comments »
Doubling of chemo dose aided some with leukemia – Boston Globe
Wednesday, September 30th, 2009LOS ANGELES – Adults with a common form of leukemia had a better chance of remission if they got a double dose of a long-used cancer drug, two new studies found. Doctors said the findings should change the standard of care for younger adults with Read More
Posted in Uncategorized | No Comments »
Obesity and Leukemia: Fat May Offer Sanctuary to Cancer Cells – U.S. News & World Report
Monday, September 28th, 2009PhysOrg.com
Obesity and Leukemia: Fat May Offer Sanctuary to Cancer CellsU.S. News & World ReportIn leukemia patients, excess fatty tissue allows cancerous cells to avoid destruction by chemotherapy drugs, a study in mice …Study: Fat tissue helps leukemia cells evade chemotherapySmartBriefFat cells block chemo drugs in children with leukemiaCBC.caStudy Finds Obesity Impairs Leukemia Treatment Response Animal [...]
Posted in Uncategorized | No Comments »
UNMC Study Shows Disparity in Lymphoma Survival Rates According to … – HealthNewsDigest.com
Monday, September 28th, 2009UNMC Study Shows Disparity in Lymphoma Survival Rates According to … – HealthNewsDigest.com
HealthNewsDigest.com
UNMC Study Shows Disparity in Lymphoma Survival Rates According to …HealthNewsDigest.com“The study highlights that despite the increase in new and innovative treatments for lymphoma, rural patients are less likely to receive optimal treatment,” …Location may affect survival of lymphoma patientsOmaha World-Heraldall 4 news [...]
Posted in Uncategorized | No Comments »
Childhood Hodgkin’s Lymphoma: Diagnosis
Monday, September 28th, 2009Childhood Hodgkin’s Lymphoma: Diagnosis Information on the diagnosis of Childhood Hodgkin’s Disease (lymphoma) Diagnosing Hodgkin’s in a child can be difficult – a parent or loved one may see changes in their child.
Posted in Uncategorized | No Comments »
Central West Virginia, What Do You Think? – Metro News
Monday, September 28th, 2009Central West Virginia, What Do You Think? – Metro NewsThe PATH debate heads to Flatwoods. The state Public Service Commission will hear the pros and cons of the proposed Potomac Appalachian Transmission Highline during two public hearings on Monday. The proposed 756 kilovolt line would start at the John
PASSINGS: Bob Stupak, Timothy J. [...]
Posted in Uncategorized | No Comments »
E.V. family draws attention to child cancer – East Valley Tribune
Sunday, September 27th, 2009CAUSE TO CELEBRATE: Hannah Ohm 7, of Gilbert looks in her bedroom mirror and smiles as the sign on her mirror reads “Done with Spinals,” meaning she has finished spinal taps as her leukemia is in remission. September has been a busy month for Read More
Bob Stupak, 67, a colorful gambler and [...]
Posted in Uncategorized | No Comments »
E.V. family draws attention to child cancer – East Valley Tribune
Sunday, September 27th, 2009CAUSE TO CELEBRATE: Hannah Ohm 7, of Gilbert looks in her bedroom mirror and smiles as the sign on her mirror reads “Done with Spinals,” meaning she has finished spinal taps as her leukemia is in remission. September has been a busy month for Read More
Bob Stupak, 67, a colorful gambler and [...]
Posted in Uncategorized | No Comments »
Genzyme’s Good News. Finally! – Motley Fool
Saturday, September 26th, 2009Genzyme’s Good News. Finally! – Motley FoolIn the trial, patients taking Campath plus Fludara took a longer time to see their cancers progress than the patients who took only Fludara. Genzyme didn’t give the full details — it’s holding them for a scientific meeting — but the results were
Debt Free League Sponsors Leukemia [...]
Posted in Uncategorized | No Comments »
FDA Approves Pralatrexate for Treatment of Peripheral T-Cell … – PR Newswire (press release)
Saturday, September 26th, 2009FDA Approves Pralatrexate for Treatment of Peripheral T-Cell …PR Newswire (press release)… US Food & Drug Administration has announced the approval of pralatrexate for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). …FDA Approves Pralatrexate Injection for Relapsed, Refractory …DG Newsall 5 news articles »
Read More…
WNCT
Doubling chemo dose helped leukemia patientsThe Associated PressAbout [...]
Posted in Uncategorized | No Comments »









